![discount label](https://static.cymitquimica.com/public/img/discount.png)
Información del producto
BRD5529 is an e3 ubiquitin ligase inhibitor. It has been shown to inhibit the inflammatory response by reducing the production of cytokines and reactive oxygen species. BRD5529 has been shown to be effective in treating bowel diseases and insulin resistance, which may be due to its ability to reduce the production of pro-inflammatory cytokines. This drug also appears to have a regulatory effect on the immune system, suppressing inflammatory responses.
Propiedades químicas
Consulta técnica sobre: 3D-IEC48878 BRD5529
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.